MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MannKind Corp (MNKD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7269
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The product consists of a dry powder formulation of human insulin delivered from a small and portable inhaler. The company develops products based on its proprietary Technosphere formulation technology. It has manufacturing facility in Danbury, Connecticut and sells its product through wholesale distributors and specialty pharmacies. MannKind is headquartered in California, the US.

MannKind Corp (MNKD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MannKind Corp, Medical Equipment, Deal Details 11
Partnerships 11
MannKind and One Drop to Enter into Agreement 11
United Therapeutics to Enter into Licensing Agreement with MannKind 12
Equity Offering 13
MannKind Raises USD28 Million in Private Placement of Shares 13
Mannkind to Raise USD61 Million in Private Placement of Shares 15
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 17
MannKind Raises USD36.2 Million in Private Placement of Shares 18
Mannkind Raises USD50 Million in Private Placment of Shares 19
MannKind Announces Public Offering Of Common Stock For US$50 Million 21
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 22
MannKind Completes Public Offering Of Units For US$86 Million 23
Debt Offering 25
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 25
MannKind Corp – Key Competitors 27
MannKind Corp – Key Employees 28
MannKind Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Sep 05, 2017: MannKind Relocates Headquarters to Westlake Village 30
Financial Announcements 31
Aug 02, 2018: MannKind Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET 31
May 09, 2018: MannKind Reports 2018 First Quarter Financial Results 33
Feb 27, 2018: MannKind Reports 2017 Fourth Quarter and Full Year Financial Results 34
Aug 07, 2017: MannKind Reports 2017 Second Quarter Financial Results 36
May 10, 2017: MannKind Reports 2017 First Quarter Financial Results 38
Mar 16, 2017: MannKind Reports 2016 Fourth Quarter and Full Year Financial Results 39
Corporate Communications 40
Feb 06, 2018: MannKind Names David Kendall As Chief Medical Officer 40
Jul 17, 2017: Steven Binder Joins MannKind as Chief Financial Officer 41
Jul 12, 2017: Patrick McCauley Joins MannKind as Chief Commercial Officer 42
Jun 28, 2017: Mannkind draws remaining funds under mann group loan arrangement 43
Jan 04, 2017: MannKind Announces Key Addition to Its Executive Management Ranks 44
Legal and Regulatory 45
Jun 25, 2018: MannKind Set to Join Russell 3000 Index 45
Other Significant Developments 46
Jan 03, 2017: MannKind Receives $1 Million Milestone From RLS 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
MannKind Corp, Medical Equipment, Key Facts, 2017 2
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Deals By Market, 2012 to YTD 2018 9
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MannKind and One Drop to Enter into Agreement 11
United Therapeutics to Enter into Licensing Agreement with MannKind 12
MannKind Raises USD28 Million in Private Placement of Shares 13
Mannkind to Raise USD61 Million in Private Placement of Shares 15
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 17
MannKind Raises USD36.2 Million in Private Placement of Shares 18
Mannkind Raises USD50 Million in Private Placment of Shares 19
MannKind Announces Public Offering Of Common Stock For US$50 Million 21
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 22
MannKind Completes Public Offering Of Units For US$86 Million 23
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 25
MannKind Corp, Key Competitors 27
MannKind Corp, Key Employees 28
MannKind Corp, Other Locations 29
MannKind Corp, Subsidiaries 29

List of Figures
MannKind Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Consolidated Edison Company of New York Inc:企業の発電所・SWOT分析2018
    Consolidated Edison Company of New York Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Tractebel Engineering S.A.:企業の戦略的SWOT分析
    Tractebel Engineering S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Randox Laboratories Ltd-医療機器分野:企業M&A・提携分析
    Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers …
  • Just the Berries Ltd:企業の戦略・SWOT・財務情報
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fidelity Investments Inc:企業のM&A・事業提携・投資動向
    Fidelity Investments Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity Investments Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Arab National Bank:企業の戦略・SWOT・財務分析
    Arab National Bank - Strategy, SWOT and Corporate Finance Report Summary Arab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lamprell Plc (LAM):企業の財務・戦略的SWOT分析
    Lamprell Plc (LAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Canadian Natural Resources, Ltd.:企業の戦略・SWOT・財務情報
    Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • 7-Eleven Inc:企業のM&A・事業提携・投資動向
    7-Eleven Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 7-Eleven Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Myriad Genetics Inc (MYGN)-医療機器分野:企業M&A・提携分析
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that are designed to …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hoya Corporation:企業の戦略・SWOT・財務情報
    Hoya Corporation - Strategy, SWOT and Corporate Finance Report Summary Hoya Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • United Supermarkets LLC:戦略・SWOT・企業財務分析
    United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report Summary United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報
    Summary EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services …
  • S.C. Hidroelectrica SA:企業の戦略的SWOT分析
    S.C. Hidroelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Church & Dwight Co Inc:戦略・SWOT・企業財務分析
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wintrust Financial Corporation:企業のM&A・事業提携・投資動向
    Wintrust Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wintrust Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Eastern Company SAE:企業の戦略・SWOT・財務情報
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆